Skip to main content
. 2009 Jan 21;2009(1):CD003595. doi: 10.1002/14651858.CD003595.pub2

Perez 1998.

Methods Country: Argentina 
 Recruitment: Single tertiary care paediatric hospital. 
 Randomised: Computer‐ generated 
 Inclusion criteria participants: yes 
 Baseline characteristics: Similar 
 Blinding 
 ‐ subject: Yes 
 ‐ therapist: No 
 ‐ assessor: Yes 
 Placebo controlled: Yes 
 Intention‐to‐treat analysis: No 
 Follow‐up: 98% (2 weeks)
Participants Inclusion criteria
  • Sex: 48 males

  • Median age: 13 months (range 9‐23)

  • Groups were similar at study entry (age, sex, seizure history, haematology, biochemistry)


Treatment group 
 Number: 45
Control group 
 Number: 47
Interventions Treatment group
  • Methylprednisolone (5 mg/kg/d), 4 times a day for 7 days

  • Supportive care


Control group
  • Placebo (matched for colour, flavour appearance)

  • Supportive care


Supportive interventions similar in both groups (type of dialysis not specified)
Outcomes
  • All‐cause mortality

  • Neurological event

  • Adverse events: peritonitis

Notes
  • HUS study

  • Diarrhoea‐associated HUS (100%)

Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Low risk A ‐ Adequate